Global Heparin Market to Reach US$ 8.9 Billion by 2032, Propelled by Rising Incidences of Chronic Health Conditions

March 23, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Heparin Market Report by Product (Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra-Low Molecular Weight Heparin (ULMWH)), Source (Bovine, Porcine), Mode of Administration (Oral, Parenteral), Application (Atrial Fibrillation & Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Others), End-User (Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Stores, and Others), and Region 2024-2032”, the global heparin market size reached US$ 7.3 Billion in 2023. Heparin (C12H19NO20S3) refers to a mucopolysaccharide with antithrombotic properties that acts as an anticoagulant or a blood thinner in pharmaceuticals. Heparin can be obtained from the liver, the lungs, mast cells, and other cells of vertebrates. It functions by inactivating thrombin and preventing the conversion of fibrinogen to fibrin which prevents the clots from becoming larger and causing more serious problems. The action of heparin in vitro and in vivo inhibits the formation of fibrin clots and the clotting of blood. Patients with unstable angina and heart-related conditions, such as acute coronary syndrome, thrombosis, and atrial fibrillation, may benefit from the use of this drug. For breaking up clots and maintaining smooth blood flow, heparin is usually injected directly into muscles or veins. It is extensively utilized in post-operative care, dialysis and blood transfusion procedures, and major orthopedic procedures, such as hip and knee replacements, for a quicker recovery.


Global Heparin Market Trends:

The global market is majorly driven by the rising incidences of chronic health conditions, such as renal impairment, hypertension, diabetes, and cardiovascular conditions among the masses. This can be attributed to the sedentary lifestyles and unhealthy food habits of the population. In line with this, the augmenting geriatric population that is more susceptible to developing these disorders is providing an impetus to the heparin market. Moreover, continual technological advancements in the development of synthetic and semi-synthetic heparin mimetics are creating lucrative growth opportunities in the market. Additionally, the advent of ultra-low molecular weight heparin for chemotherapy, innovative medicines with reduced side-effects and effective carbohydrate synthesis procedures are positively impacting the market. The market is further propelled by the rising healthcare expenditure, along with the rising government investments in enhancing healthcare services on the global level. Apart from this, numerous strategies adopted by the key players, such as mergers and acquisitions (M&As) and partnerships and collaborations to enhance their geographical presence are fueling the market. Some of the other factors contributing to the market include rapid urbanization, considerable growth in the pharmaceutical industry, inflating disposable income levels of the consumers and extensive research and development (R&D) activities. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 8.9 Billion by 2032, exhibiting a CAGR of 2.2% during 2024-2032.


Market Summary:

  • Based on the product, the market has been segmented into unfractionated heparin, Low Molecular Weight Heparin (LMWH), and Ultra-Low Molecular Weight Heparin (ULMWH).
  • On the basis of the source, the market has been divided into bovine and porcine.
  • Based on the mode of administration, the market has been classified into oral and parenteral.
  • On the basis of the application, the market has been segmented into atrial fibrillation & heart attack, stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and others.
  • Based on the end-user, the market has been categorized into hospitals, clinics, homecare settings, ambulatory surgical centers, and others.
  • On the basis of the distribution channel, the market has been classified into hospital pharmacies, retail pharmacies, drug stores, online stores, and others.
  • On the geographical front, the market has been segregated into Europe, North America, Asia-Pacific, Middle East and Africa, and Latin America.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of these players include GlaxoSmithKline Plc, Shenzhen Hepalink Pharmaceutical Co., Ltd, Pfizer Inc., LEO Pharma A/S, Sanofi S.A., Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Aspen Holdings, Baxter International Inc., Hebei Changshan Biochemical Pharmaceutical Co. Ltd., Sandoz International GmbH, Opocrin S.p.A., Sichuan Deebio Pharmaceutical Co., Ltd., and Dongying Tiandong Pharmaceutical Co., Ltd.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Product, Source, Mode of Administration, Application, End-User, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered GlaxoSmithKline Plc, Shenzhen Hepalink Pharmaceutical Co., Ltd, Pfizer Inc., LEO Pharma A/S, Sanofi S.A., Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Aspen Holdings, Baxter International Inc., Hebei Changshan Biochemical Pharmaceutical Co. Ltd., Sandoz International GmbH, Opocrin S.p.A., Sichuan Deebio Pharmaceutical Co., Ltd. and Dongying Tiandong Pharmaceutical Co., Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact Us:

IMARC Group
30 N A
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Heparin Market to Reach US$ 8.9 Billion by 2032, Propelled by Rising Incidences of Chronic Health Conditions
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More